Last Close
Apr 09  •  10:37AM ET
2.82
Dollar change
-0.09
Percentage change
-3.09
%
Index
-
P/E
25.52
EPS (ttm)
0.11
Insider Own
11.31%
Shs Outstand
10.64M
Perf Week
-4.73%
Market Cap
30.01M
Forward P/E
21.69
EPS next Y
0.13
Insider Trans
0.00%
Shs Float
9.44M
Perf Month
-31.05%
Enterprise Value
25.67M
PEG
-
EPS next Q
0.01
Inst Own
49.81%
Perf Quarter
-45.35%
Income
1.19M
P/S
1.60
EPS this Y
-45.45%
Inst Trans
2.93%
Perf Half Y
-50.35%
Sales
18.79M
P/B
2.94
EPS next Y
116.67%
ROA
9.61%
Perf YTD
-42.21%
Book/sh
0.96
P/C
5.56
EPS next 5Y
-
ROE
12.71%
52W High
6.42 -56.07%
Perf Year
50.80%
Cash/sh
0.51
P/FCF
18.19
EPS past 3/5Y
- -
ROIC
10.98%
52W Low
1.64 71.95%
Perf 3Y
102.88%
Dividend Est.
-
EV/EBITDA
19.90
Sales past 3/5Y
23.50% 17.02%
Gross Margin
61.13%
Volatility
5.30% 6.25%
Perf 5Y
-65.06%
Dividend TTM
-
EV/Sales
1.37
EPS Y/Y TTM
1531.88%
Oper. Margin
6.10%
ATR (14)
0.20
Perf 10Y
11.51%
Dividend Ex-Date
-
Quick Ratio
2.89
Sales Y/Y TTM
32.67%
Profit Margin
6.35%
RSI (14)
36.48
Dividend Gr. 3/5Y
- -
Current Ratio
4.06
EPS Q/Q
-83.38%
SMA20
-6.23%
Beta
1.52
Payout
0.00%
Debt/Eq
0.10
Sales Q/Q
22.20%
SMA50
-21.99%
Rel Volume
0.21
Prev Close
2.91
Employees
36
LT Debt/Eq
0.07
SMA200
-34.39%
Avg Volume
47.20K
Price
2.82
IPO
Sep 21, 2004
Option/Short
No / Yes
Trades
Volume
2,103
Change
-3.09%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
Apr-01-26 09:00AM
Mar-13-26 09:02PM
08:30AM
Mar-12-26 04:10PM
Mar-05-26 07:04AM
08:16AM Loading…
Feb-13-26 08:16AM
Dec-11-25 09:00AM
Nov-10-25 08:04PM
Nov-06-25 04:10PM
Oct-30-25 04:00PM
Oct-08-25 09:00AM
Oct-07-25 10:41AM
Aug-08-25 11:00PM
Aug-07-25 04:00PM
Jul-31-25 04:00PM
09:19AM Loading…
Jul-15-25 09:19AM
May-28-25 09:00AM
May-08-25 04:00PM
May-07-25 11:46AM
Apr-30-25 04:00PM
Apr-28-25 09:00AM
Mar-06-25 04:00PM
Mar-05-25 07:36AM
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
09:00AM Loading…
Oct-24-24 09:00AM
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Banks Robert R. Jr.President and CEOMar 23 '26Option Exercise1.44120,000172,800190,000Mar 25 04:54 PM
Krandel JudyChief Financial OfficerMar 23 '26Option Exercise1.7168,861117,75268,861Mar 25 04:53 PM